Joint Announcement Regarding The Intended Consensual Termination Of The Transaction Implementation Agreement ("TIA") Between Adcock Ingram And CFR Pharmaceuticals ("The Parties")
2/7/2014 9:19:59 AM
SANTIAGO, Chile, Feb. 7, 2014 (GLOBE NEWSWIRE) -- CFR Pharmaceuticals S.A. (SSE: CFR), the Chilean multinational emerging markets pharmaceutical company, leader in specialties and prescription medicines, refers shareholders to the announcements released on the Stock Exchange News Service ("SENS") of the JSE Limited by Adcock Ingram Holdings Limited ("Adcock") and by The Bidvest Group Limited ("Bidvest") on Friday, 31 January 2014, regarding the acquisition by a consortium comprising Bidvest and Community Investment Holdings (Pty) Limited of approximately 34.5% of the ordinary issued share capital of Adcock.
Help employers find you! Check out all the jobs and post your resume.
comments powered by